Recharge Metals Limited (REC)
CXA 
BATS Primary CXA Summary
Recursion: Path Forward For REC-994 Remains Despite Mixed Response
Recursion Pharmaceuticals, Inc.'s REC-994 was able to show positive safety/tolerability data for the treatment of Cerebral Cavernous Malformation, along with a trend towards improvement. End-of-phase 2 meeting with FDA will shed more light on required approval efficacy endpoint for CCM and other trial changes to move forward with, like higher dosing and longer-duration treatment. REC-2282 for Neurofibromatosis Type 2 and REC-4881 for Familial Adenomatous Polyposis are other programs being advanced; Data from each expected Q4 of 2024 and 1st half of 2025 respectively.
Recharge Metals Limited (REC) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Recharge Metals Limited ever had a stock split?
Recharge Metals Limited Profile
| - Industry | - Sector | - CEO | CXA Exchange | US2913616080 ISIN |
| United States Country | - Employees | 13 Oct 2022 Last Dividend | - Last Split | - IPO Date |
Overview
The index represents a specific financial strategy focused on the real estate sector within the United States. It is designed as a market value weighted index, which aims to gauge the performance of corporate bonds issued by U.S. companies and their subsidiaries operating in the real estate market. By adhering to a model that invests a minimum of 90% of its net assets, alongside any borrowings for investment purposes, directly into the securities that make up the index, it ensures an alignment with the performance of the said sector. This approach is complemented with the possibility of investing up to 10% of its assets in derivatives such as futures, options, and swaps, in addition to holding cash and cash equivalents. An important characteristic of this financial entity is its non-diversified status, indicating a focused investment strategy in a specific sector of the market.
Products and Services
- Corporate Bonds Investment
The core product revolves around investing in corporate bonds specifically issued by companies operating in the U.S. real estate sector. These bonds represent debt securities issued by firms to raise capital, with the index focusing on those that impact the real estate industry. Such investments are aimed at generating returns through interest earnings and capital appreciation over time.
- Derivatives Investment
Up to 10% of the fund's assets may be allocated to investment in derivatives such as futures, options, and swap contracts. These financial instruments are used to hedge against market risks or speculate on future movements of asset prices within the real estate sector, providing a potential for additional income or to safeguard the portfolio's value.
- Cash and Cash Equivalents
A portion of the fund's investment strategy includes holding cash or cash equivalents. This not only ensures liquidity, allowing the fund to meet its short-term obligations and operational costs but also offers a safety net in times of market volatility or unexpected downturns. Balancing the portfolio with liquid assets is a crucial aspect of managing investment risk and protecting the portfolio’s value.
